TCI was retained by an angel investment fund to lead the sale of a majority stake in a medical device company to a strategic buyer.
TCI quickly grasped the core strengths of the business as well as weaknesses that could be supplemented by approaching strategic investors. By leveraging investment contacts across industries, TCI was able to identify a strong strategic buyer match that strengthened the business while freeing up capital for the angel investors. TCI led the valuation due diligence and handled all deal negotiations. The resulted sale returned over 75% IRR to investors.